Immunology

FDA adds Fasenra indication for severe asthma in children

The U.S. Food and Drug Administration has approved an additional indication for AstraZeneca's Fasenra (benralizumab) as an add-on maintenance treatment for patients aged 6 to 11 years with severe asthma and an eosinophilic ...

Diseases, Conditions, Syndromes

Meningococcal disease on the rise in the US

A rise in invasive serogroup Y meningococcal disease has prompted the Centers for Disease Control and Prevention (CDC) to issue a health advisory for health care providers.

page 3 from 8